Statement Of Comprehensive Income [Abstract]

Tchaikapharma High Quality Medicines AD - Filing #6023728

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Statement of comprehensive income [abstract]
Profit (loss)	- BGN	- BGN	3 398 BGN	- BGN	- BGN	3 398 BGN	3 398 BGN	- BGN	- BGN	- BGN	2 790 BGN	2 790 BGN	2 790 BGN	- BGN
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, before tax [abstract]
Other comprehensive income, before tax, gains (losses) on revaluation of property, plant and equipment, right-of-use assets and intangible assets	—	—	- BGN	—	—	—	—	—	—	—	- BGN	—	—	—
Income tax relating to components of other comprehensive income that will not be reclassified to profit or loss [abstract]
Income tax relating to remeasurements of defined benefit plans included in other comprehensive income	—	—	3,000 BGN	—	—	—	—	—	—	—	2,000 BGN	—	—	—
Other comprehensive income	- BGN	- BGN	18,000 BGN	18,000 BGN	- BGN	- BGN	18,000 BGN	- BGN	24,000 BGN	- BGN	24,000 BGN	24,000 BGN	- BGN	- BGN
Comprehensive income	- BGN	- BGN	3 416 BGN	18,000 BGN	- BGN	3 398 BGN	3 416 BGN	- BGN	24,000 BGN	- BGN	2 766 BGN	2 766 BGN	2 790 BGN	- BGN
Comprehensive income attributable to [abstract]
Comprehensive income, attributable to owners of parent	—	—	3 416 BGN	—	—	—	—	—	—	—	2 766 BGN	—	—	—
Comprehensive income, attributable to non-controlling interests	—	—	- BGN	—	—	—	—	—	—	—	- BGN	—	—	—